RicklesF.R.LevineM.N.: Venous thromboembolism in malignancy and malignancy in venous thromboembolism.Haemostasis, 28(suppl 3): 43–49, 1998.
2.
LeeA.Y.Y.LevineM.N.: Management of venous thromboembolism in cancer patients.Oncology, 14: 409–421, 2000.
3.
LeeA.Y.Y.JulianJ.A.LevineM.N.WeitzJ.I.KearonC.WellsP.S.GinsbergJ.S.: The clinical utility of a rapid whole-blood D-dimer assay in patients with cancer who present with suspected acute deep venous thrombosis.Ann Intern Med, 131: 417–423, 1999.
4.
GefterW.B.HatabuH.HollandG.A.GuptaK.B.HenschkeC.I.PalevskyH.I.: Pulmonary thromboembolism: recent developments in diagnosis with CT and MR imaging.Radiology, 197: 561–574, 1995.
5.
LevineM.HirshJ.GentM.ArnoldA.WarrD.FalangaA.SamoshM.BramwellV.PritchardK.I.StewartD.: Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer.Lancet, 343: 886–889, 1994.
6.
SamamaM.M.CohenA.T.DarmonJ-Y, DesjardinsL.EldorA.JanbonC.LeizoroviczA.NguyenH.OlssonC.G.TurpieA.G.WeisslingerN.: A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients.N Engl J Med, 341: 793–800, 1999.
7.
BernM.M.LokichJ.J.WallachS.R.BotheAJr., BenottiP.N.ArkinC.F.GrecoF.A.HubermanM.MooreC.: Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial.Ann Intern Med, 112: 423–428, 1990.
8.
MonrealM.AlastrelA.RullM.MiraX.MuxartJ.RosellR.AbadA.: Upper extremity deep vein thrombosis in cancer patients with venous access devices – prophylaxis with a low molecular weight heparin (Fragmin).Thromb Haemost, 75: 251–253, 1996.
ZacharskiL.OrnsteinD.: Heparin and cancer.Thrombosis & Haemostasis, 80: 10–23, 1998.
11.
SchulmanS.LindmarkerP.for the Duration of Anticoagulation Trial: Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism.N Eng J Med, 342: 1953–1958, 2000.
